December 18, 2013
Diovan Investigative Committee of Chiba University Chiba University found no evidence indicating that its clinical study on Novartis Pharma’s hypertension drug Diovan (valsartan) was intentionally manipulated, the university said in its interim report released on December 17. The institution is...read more